5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A triple suicide gene strategy that improves therapeutic effects and incorporates multimodality molecular imaging for monitoring gene functions
    Journal Article

    Xing, L.; Sun, X.; Deng, X.; Kotedia, K.; Zanzonico, P. B.; Ackerstaff, E.; Koutcher, J. A.; Ling, C. C.; Li, G. C.
    Cancer Gene Therapy (2013)

    Fulltext@MSK | Save
  • Perspectives on immunotherapy in prostate cancer and solid tumors: Where is the future?
    Journal Article

    Snyder, A.; Tepper, J. E.; Slovin, S. F.
    Seminars in Oncology (2013)

    Fulltext@MSK | Save
  • Axitinib in metastatic renal cell carcinoma: Results of a pharmacokinetic and pharmacodynamic analysis
    Journal Article

    Rini, B. I.; Garrett, M.; Poland, B.; Dutcher, J. P.; Rixe, O.; Wilding, G.; Stadler, W. M.; Pithavala, Y. K.; Kim, S.; Tarazi, J.; more...
    Journal of Clinical Pharmacology (2013)

    Fulltext@MSK | Save
  • ERK pathway inhibitors: How low should we go?
    Journal Article

    Nissan, M. H.; Rosen, N.; Solit, D. B.
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Escudier, B.; Bukowski, R.; Rini, B. I.; Hutson, T. E.; Barrios, C. H.; Lin, X.; Fly, K.; Matczak, E.; Gore, M. E.
    British Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Monitoring the clinical outcomes in advanced prostate cancer: What imaging modalities and other markers are reliable?
    Journal Article

    Morris, M. J.; Autio, K. A.; Basch, E. M.; Danila, D. C.; Larson, S.; Scher, H. I.
    Seminars in Oncology (2013)

    Fulltext@MSK | Save
  • A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer
    Journal Article

    Lin, J.; Zahurak, M.; Beer, T. M.; Ryan, C. J.; Wilding, G.; Mathew, P.; Morris, M.; Callahan, J. A.; Gordon, G.; Reich, S. D.; more...
    Urologic Oncology: Seminars and Original Investigations (2013)

    Fulltext@MSK | Save
  • Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA research network
    Journal Article

    Hakimi, A. A.; Ostrovnaya, I.; Reva, B.; Schultz, N.; Chen, Y. B.; Gonen, M.; Liu, H.; Takeda, S.; Voss, M. H.; Tickoo, S. K.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older
    Journal Article

    Feldman, D. R.; Voss, M. H.; Jacobsen, E. P.; Jia, X.; Suarez, J. A.; Turkula, S.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.; Patil, S.
    Cancer (2013)

    Fulltext@MSK | Save
  • Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors
    Journal Article

    Cavallo, F.; Feldman, D. R.; Barchi, M.
    International Journal of Developmental Biology (2013)

    Fulltext@MSK | Save